Published date: Oct 30 2024

Journal Title: Dubai Medical Journal

Issue title: Dubai Medical Journal (DMJ): Volume 7 Issue 1

Pages: 39–54

DOI: 10.18502/dmj.v7i1.17498

Mathiyazhagan Narayananmathimicro@gmail.comCenter for Research and Innovations, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Science (SIMATS), Chennai-602 105, Tamil Nadu

Mani AyyanduraiCenter for Research and Innovations, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Science (SIMATS), Chennai-602 105, Tamil Nadu

V. RajinikanthCenter for Research and Innovations, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Science (SIMATS), Chennai-602 105, Tamil Nadu

Introduction: The beginning of exosome biosynthesis is marked by the emergence of the initial endosomes through the inward splitting of the plasma cell membrane. This process is facilitated through the endosomal categorization complex essential for transport, which is also involved in the production of different extracellular vesicles. Exosomes are naturally occurring nanosized vesicles found in all bodily fluids and can be successfully extracted from preserved biological materials, while maintaining their structural integrity.

Methods: The articles published recently in high-quality journals (Science Direct, Springer, Institute of Electrical and Electronics Engineers (IEEE), and Taylor & Francis) indexed in various indexing sources such as Scopus, Web of Science, PubMed, Google Scholar, and so on were collected using keywords such as fluid biopsy (FB) exosomes, endosomes, and noncommunicable diseases (NCDs) treatment, new biomarkers, and treatment.

Discussion: In recent years, exosomes have emerged as an exciting option for “FB” that has demonstrated significant potential in the areas of noninvasive medical testing, predictions, as well as tracking responses to therapy for noncommunicable diseases. Nevertheless, specific constraints need to be addressed to expand the application of exosome-based FB as a widely accepted and reliable testing method in typical medical facilities.

Conclusion: This review provides a comprehensive overview of our present understanding of exosomes to be an FB method for diagnosing, predicting outcomes, and tracking treatment responses in NCDs. It also discusses the main constraints, innovations in technology, as well as future possibilities of using this application in medical treatment.

Keywords: fluid biopsy, disease progression, diagnosis, treatment response monitoring, healthcare

[1] Connal S, Cameron JM, Sala A, Brennan PM, Palmer DS, Palmer JD, et al. Liquid biopsies: The future of cancer early detection. J Transl Med. 2023 Feb;21(1):118.

[2] Di Bella MA. Overview and update on extracellular vesicles: Considerations on exosomes and their application in modern medicine. Biology (Basel). 2022 May;11(6):804.

[3] Ratajczak MZ, Ratajczak J. Extracellular microvesicles/exosomes: Discovery, disbelief, acceptance, and the future? Leukemia. 2020 Dec;34(12):3126–3135.

[4] Dwivedi M, Ghosh D, Saha A, Hasan S, Jindal D, Yadav H, et al. Biochemistry of exosomes and their theranostic potential in human diseases. Life Sci. 2023 Feb;315:121369.

[5] Yu W, Hurley J, Roberts D, Chakrabortty SK, Enderle D, Noerholm M, et al. Exosome-based liquid biopsies in cancer: Opportunities and challenges. Ann Oncol. 2021 Apr;32(4):466–477.

[6] Huda MN, Nafiujjaman M, Deaguero IG, Okonkwo J, Hill ML, Kim T, et al. Potential use of exosomes as diagnostic biomarkers and in targeted drug delivery: Progress in clinical and preclinical applications. ACS Biomater Sci Eng. 2021 Jun;7(6):2106–2149.

[7] Avgoulas DI, Tasioulis KS, Papi RM, Pantazaki AA. Therapeutic and diagnostic potential of exosomes as drug delivery systems in brain cancer. Pharmaceutics. 2023 May;15(5):1439.

[8] González Á, López-Borrego S, Sandúa A, Vales-Gomez M, Alegre E. Extracellular vesicles in cancer: challenges and opportunities for clinical laboratories. Crit Rev Clin Lab Sci. 2024 Sep;61(6):435–457.

[9] Barrachina MN, Calderón-Cruz B, Fernandez-Rocca L, García Á. Application of extracellular vesicles proteomics to cardiovascular disease: Guidelines, data analysis, and future perspectives. Proteomics. 2019 Jan;19(1-2):e1800247.

[10] Bejleri J, Jirström E, Donovan P, Williams DJ, Pfeiffer S. Diagnostic and prognostic circulating microRNA in acute stroke: A systematic and bioinformatic analysis of current evidence. J Stroke. 2021 May;23(2):162–182.

[11] Wu X, Xia P, Yang L, Lu C, Lu Z. The roles of long non-coding RNAs in Alzheimer’s disease diagnosis, treatment, and their involvement in Alzheimer’s disease immune responses. Noncoding RNA Res. 2024 Mar;9(3):659–666.

[12] Abdel-Haq H. The potential of liquid biopsy of the brain using blood extracellular vesicles: The first step toward effective neuroprotection against neurodegenerative diseases. Mol Diagn Ther. 2020 Dec;24(6):703–713.

[13] Vilaça-Faria H, Salgado AJ, Teixeira FG. Mesenchymal stem cells-derived exosomes: A new possible therapeutic strategy for Parkinson’s disease? Cells. 2019 Feb;8(2):118.

[14] Raghavan V, Bhomia M, Torres I, Jain S, Wang KK. Hypothesis: Exosomal microRNAs as potential biomarkers for schizophrenia. Med Hypotheses. 2017 Jun;103:21–25.

[15] Khachatoorian Y, Khachadourian V, Chang E, Sernas ER, Reed EF, Deng M, et al. Noninvasive biomarkers for prediction and diagnosis of heart transplantation rejection. Transplant Rev (Orlando). 2021 Jan;35(1):100590.

[16] Burrello J, Monticone S, Burrello A, Bolis S, Cristalli CP, Comai G, et al. Identification of a serum and urine extracellular vesicle signature predicting renal outcome after kidney transplant. Nephrol Dial Transplant. 2023 Feb;38(3):764–777.

[17] Boriachek K, Islam MN, Möller A, Salomon C, Nguyen NT, Hossain MS, et al. Biological functions and current advances in isolation and detection strategies for exosome nanovesicles. Small. 2018 Feb;14(6):1702153.

[18] Mehryab F, Rabbani S, Shahhosseini S, Shekari F, Fatahi Y, Baharvand H, et al. Exosomes as a nextgeneration drug delivery system: An update on drug loading approaches, characterization, and clinical application challenges. Acta Biomater. 2020 Sep;113:42–62.

[19] Rezaie J, Feghhi M, Etemadi T. A review on exosomes application in clinical trials: Perspective, questions, and challenges. Cell Commun Signal. 2022 Sep;20(1):145.

[20] Welsh JA, Goberdhan DC, O’Driscoll L, Buzas EI, Blenkiron C, Bussolati B, et al.; MISEV Consortium. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024 Feb;13(2):e12404.

[21] Yadav R, Singh AV, Kushwaha S, Chauhan DS. Emerging role of exosomes as a liquid biopsy tool for diagnosis, prognosis, monitoring treatment response of communicable & non-communicable diseases. Indian J Med Res. 2024 Feb;159(2):163–180.

[22] Marjani AA, Nader ND, Aghanejad A. Exosomes as targeted diagnostic biomarkers: recent studies and trends. Life Sci. 2024 Oct;354:122985.

[23] Jafari D, Shajari S, Jafari R, Mardi N, Gomari H, Ganji F, et al. Designer exosomes: A new platform for biotechnology therapeutics. BioDrugs. 2020 Oct;34(5):567–586.

[24] Wang CK, Tsai TH, Lee CH. Regulation of exosomes as biologic medicines: Regulatory challenges faced in exosome development and manufacturing processes. Clin Transl Sci. 2024 Aug;17(8):e13904.

[25] Davies OG, Williams S, Goldie K. The therapeutic and commercial landscape of stem cell vesicles in regenerative dermatology. J Control Release. 2023 Jan;353:1096–1106.

[26] Castellanos-Rizaldos E, Grimm DG, Tadigotla V, Hurley J, Healy J, Neal PL, et al. Exosome-based detection of EGFR T790M in plasma from non–small cell lung cancer patients. Clin Cancer Res. 2018 Jun;24(12):2944–2950.

[27] Li L, Zhang L, Montgomery KC, Jiang L, Lyon CJ, Hu TY. Advanced technologies for molecular diagnosis of cancer: State of pre-clinical tumor-derived exosome liquid biopsies. Mater Today Bio. 2022 Dec;18:100538.

[28] Fotuhi SN, Khalaj-Kondori M, Hoseinpour Feizi MA, Talebi M. Long non-coding RNA BACE1-AS may serve as an Alzheimer’s disease blood-based biomarker. J Mol Neurosci. 2019 Nov;69(3):351–359.

[29] Elbay A, Ercan Ç, Akbaş F, Bulut H, Ozdemir H. Three new circulating microRNAs may be associated with wet age-related macular degeneration. Scand J Clin Lab Invest. 2019 Oct;79(6):388–394.

[30] Hannafon BN, Trigoso YD, Calloway CL, Zhao YD, Lum DH, Welm AL, et al. Plasma exosome microRNAs are indicative of breast cancer. Breast Cancer Res. 2016 Sep;18(1):90.

[31] Armstrong DA, Green BB, Seigne JD, Schned AR, Marsit CJ. MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer. Mol Cancer. 2015 Nov;14(1):194.

[32] Dong L, Lin W, Qi P, Xu MD, Wu X, Ni S, et al. Circulating long RNAs in serum extracellular vesicles: Their characterization and potential application as biomarkers for diagnosis of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1158–1166.

[33] Arbelaiz A, Azkargorta M, Krawczyk M, Santos-Laso A, Lapitz A, Perugorria MJ, et al. Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma. Hepatology. 2017 Oct;66(4):1125–1143.

[34] Zubiri I, Posada-Ayala M, Sanz-Maroto A, Calvo E, Martin-Lorenzo M, Gonzalez-Calero L, et al. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis. J Proteomics. 2014 Jan;96:92–102.

[35] Biró O, Alasztics B, Molvarec A, Joó J, Nagy B, Rigó J Jr. Various levels of circulating exosomal totalmiRNA and miR-210 hypoxamiR in different forms of pregnancy hypertension. Pregnancy Hypertens. 2017 Oct;10:207–212.

[36] Zhang H, Huang E, Kahwaji J, Nast CC, Li P, Mirocha J, et al. Plasma exosomes from HLA-sensitized kidney transplant recipients contain mRNA transcripts which predict development of antibodymediated rejection. Transplantation. 2017 Oct;101(10):2419–2428.

[37] Perez-Hernandez J, Olivares D, Forner MJ, Ortega A, Solaz E, Martinez F, et al. Urinary exosome miR- 146a is a potential marker of albuminuria in essential hypertension. J Transl Med. 2018 Aug;16(1):228.

[38] Cheow ES, Cheng WC, Lee CN, de Kleijn D, Sorokin V, Sze SK. Plasma-derived extracellular vesicles contain predictive biomarkers and potential therapeutic targets for myocardial ischemic (MI) injury. Mol Cell Proteomics. 2016 Aug;15(8):2628–2640.

[39] Salomon C, Guanzon D, Scholz-Romero K, Longo S, Correa P, Illanes SE, et al. Placental exosomes as early biomarker of preeclampsia: Potential role of exosomal microRNAs across gestation. J Clin Endocrinol Metab. 2017 Sep;102(9):3182–94.

[40] Sukma Dewi I, Celik S, Karlsson A, Hollander Z, Lam K, McManus JW, et al. Exosomal miR-142-3p is increased during cardiac allograft rejection and augments vascular permeability through downregulation of endothelial RAB11FIP2 expression. Cardiovasc Res. 2017 Apr;113(5):440–452.

[41] McKiernan J, Donovan MJ, O’Neill V, Bentink S, Noerholm M, Belzer S, et al. A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy. JAMA Oncol. 2016 Jul;2(7):882–889.

[42] Goetzl EJ, Abner EL, Jicha GA, Kapogiannis D, Schwartz JB. Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer’s disease. FASEB J. 2018 Feb;32(2):888–893.

[43] Rodríguez-Martínez A, de Miguel-Pérez D, Ortega FG, García-Puche JL, Robles-Fernández I, Exposito J, et al. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy. Breast Cancer Res. 2019 Feb;21(1):21.

[44] Lin Y, Dong H, Deng W, Lin W, Li K, Xiong X, et al. Evaluation of salivary exosomal chimeric GOLM1-NAA35 RNA as a potential biomarker in esophageal carcinoma. Clin Cancer Res. 2019 May;25(10):3035–3045.

[45] Fernandez-García CE, Burillo E, Lindholt JS, Martinez-Lopez D, Pilely K, Mazzeo C, et al. Association of ficolin-3 with abdominal aortic aneurysm presence and progression. J Thromb Haemost. 2017 Mar;15(3):575–585.

[46] Kennel PJ, Saha A, Maldonado DA, Givens R, Brunjes DL, Castillero E, et al. Serum exosomal protein profiling for the non-invasive detection of cardiac allograft rejection. J Heart Lung Transplant. 2018 Mar;37(3):409–417.

[47] Jiang R, Rong C, Ke R, Meng S, Yan X, Ke H, et al. Differential proteomic analysis of serum exosomes reveals alterations in progression of Parkinson disease. Medicine (Baltimore). 2019 Oct;98(41):e17478.

[48] Salomon C, Scholz-Romero K, Sarker S, Sweeney E, Kobayashi M, Correa P, et al. Gestational diabetes mellitus is associated with changes in the concentration and bioactivity of placenta-derived exosomes in maternal circulation across gestation. Diabetes. 2016 Mar;65(3):598–609.

[49] Ebrahimkhani S, Vafaee F, Young PE, Hur SS, Hawke S, Devenney E, et al. Exosomal microRNA signatures in multiple sclerosis reflect disease status. Sci Rep. 2017 Oct;7(1):14293.

[50] Li L, Li W, Chen N, Zhao H, Xu G, Zhao Y, et al. FLI1 exonic circular RNAs as a novel oncogenic driver to promote tumor metastasis in small cell lung cancer. Clin Cancer Res. 2019 Feb;25(4):1302–1317.

[51] Alegre E, Sanmamed MF, Rodriguez C, Carranza O, Martín-Algarra S, González A. Study of circulating microRNA-125b levels in serum exosomes in advanced melanoma. Arch Pathol Lab Med. 2014 Jun;138(6):828–832.

[52] Lea J, Sharma R, Yang F, Zhu H, Ward ES, Schroit AJ. Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: A proof of concept study. Oncotarget. 2017 Feb;8(9):14395–14407.

[53] Bijnsdorp IV, Geldof AA, Lavaei M, Piersma SR, van Moorselaar RJ, Jimenez CR. Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients. J Extracell Vesicles. 2013 Dec;2(1):22097.

[54] Liang C, Zhang L, Lian X, Zhu T, Zhang Y, Gu N. Circulating exosomal SOCS2-AS1 acts as a novel biomarker in predicting the diagnosis of coronary artery disease. BioMed Res Int. 2020 Apr;2020:9182091.

[55] Weber A, Liu SS, Cardone L, Rellecke P, Sixt SU, Lichtenberg A, et al. The course of circulating small extracellular vesicles in patients undergoing surgical aortic valve replacement. BioMed Res Int. 2020 Apr;2020:6381396.

[56] Chen G, Huang AC, Zhang W, Zhang G, Wu M, Xu W, et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018 Aug;560(7718):382–386.

[57] Parakrama R, Fogel E, Chandy C, Augustine T, Coffey M, Tesfa L, et al. Immune characterization of metastatic colorectal cancer patients post reovirus administration. BMC Cancer. 2020 Jun;20(1):569.

[58] Manna S, Tripathy S, Sah RK, Padhi BK, Kaur S, Nowrouzi-Kia B, et al. The burden of non-communicable diseases (NCDs) among prisoners in India: A systematic review and meta-analysis. Healthcare (Basel). 2022 Oct;10(10):2046.

[59] Padhi BK, Singh S, Gaidhane AM, Abu Serhan H, Khatib MN, Zahiruddin QS, et al. Inequalities in cardiovascular disease among elderly Indians: A gender perspective analysis using LASI wave-I (2017- 18). Curr Probl Cardiol. 2024 Jul;49(7):102605.

[60] Nalinipriya G, Suneetha M, Mikhailova M, Ramesh SN, Kumar KV. Leveraging double-valued neutrosophic set for real-time chronic kidney disease detection and classification. Int J Neutrosophic Sci. 2025 Jan;(1):279–290.